| |
|
|
|
|
|
|
|
|
1. |
Record Nr. |
UNINA9910690658903321 |
|
|
Titolo |
Relative effectiveness and cost-effectiveness of methods of androgen suppression in the treatment of advanced prostatic cancer [[electronic resource]] |
|
|
|
|
|
|
|
Pubbl/distr/stampa |
|
|
[Rockville, Md.] : , : [U.S. Dept. of Health and Human Services, Public Health Service, Agency for Health Care Policy and Research], , [1999] |
|
|
|
|
|
|
|
|
|
Collana |
|
Evidence report/technology assessment. Summary ; ; no. 4 |
AHCPR publication ; ; no. 99-E011 |
|
|
|
|
|
|
|
|
Soggetti |
|
Prostate - Cancer - Hormone therapy |
Antiandrogens - Therapeutic use |
Androgen Antagonists - therapeutic use |
Cost-Benefit Analysis |
Gonadotropin-Releasing Hormone - antagonists & inhibitors |
Outcome Assessment, Health Care |
Prostatic Neoplasms - drug therapy |
Randomized Controlled Trials as Topic |
|
|
|
|
|
|
|
|
Lingua di pubblicazione |
|
|
|
|
|
|
Formato |
Materiale a stampa |
|
|
|
|
|
Livello bibliografico |
Monografia |
|
|
|
|
|
Note generali |
|
Title from title screen (viewed on Apr. 29, 2004). |
"January 1999." |
"The full evidence report from which this summary was taken was prepared by the Evaluation Technology Center, an AHCPR Evidence-based Practice Center of the Blue Cross and Blue Shield Association, Chicago, Illinois, under contract no. 290-97-0015." |
|
|
|
|
|
|
|
| |